Wells Fargo & Company Processa Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.18 - $0.84 $1 - $7	9 Added 0.28%	3,247 $1,000
Q3 2023 Nov 13, 2023	BUY	$0.24 - $0.53 $4 - $9	18 Added 0.56%	3,238 $0
Q2 2023 Aug 15, 2023	BUY	$0.44 - $0.73 $28 - $47	65 Added 2.06%	3,220 $1,000
Q1 2023 May 12, 2023	BUY	$0.41 - $1.3 $0 - $2	2 Added 0.06%	3,155 $1,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $50.0 $2 - $100	2 Added 0.06%	3,153 $3,000
Q3 2022 Nov 14, 2022	BUY	$2.0 - $46.8 $12 - $280	6 Added 0.19%	3,151 $7,000
Q2 2022 Aug 12, 2022	BUY	$1.68 - $3.55 $10 - $21	6 Added 0.19%	3,145 $9,000
Q1 2022 May 16, 2022	BUY	$3.01 - $5.21 $9,258 - $16,025	3,076 Added 4882.54%	3,139 $9,000
Q3 2021 Nov 15, 2021	BUY	$5.28 - $8.61 $15 - $25	3 Added 5.0%	63 $1,000
Q2 2021 Aug 16, 2021	BUY	$6.15 - $10.95 $116 - $208	19 Added 46.34%	60 $0
Q4 2020 Feb 09, 2021	BUY	$3.95 - $8.48 $161 - $347	41 New	41 $0

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.